Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03240809 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects

StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Jul 2024 to Dec 2028 Trial status: Recruiting to Active, Not Recruiting · Enrollment target: estimated 16 to confirmed 2 · Completion date: Jul 2024 to Jun 2029 · 1 morev9 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 16 to confirmed 2
    • Completion date: Jul 2024 to Jun 2029
    • Site details revised at 5 of 5 sites
  2. Primary and study completion dates: Jul 2023 to Jul 2024v8
  3. Primary and study completion dates: Jul 2022 to Jul 2023v7
  4. Primary and study completion dates: Jul 2021 to Jul 2022v6
  5. Primary and study completion dates: Mar 10, 2021 to Jul 2021v5
Show 3 earlier versionsHide 3 earlier versions
  1. Study sites: 1 to 5 Start date changed from estimate of Jan 30, 2020 to Jan 24, 2020v4 Show 1 more changeShow less
    • Start date changed from estimate of Jan 30, 2020 to Jan 24, 2020
  2. Trial status: Not Yet Recruiting to Recruiting Primary completion date: Apr 15, 2019 to Mar 10, 2021 · Start date: Jul 12, 2018 to Jan 30, 2020 · Study sites: 0 to 1 · 1 morev3 Show 4 more changesShow less
    • Primary completion date: Apr 15, 2019 to Mar 10, 2021
    • Start date: Jul 12, 2018 to Jan 30, 2020
    • Study sites: 0 to 1
    • Completion date: Sep 15, 2019 to Mar 10, 2021
  3. Start date: Dec 12, 2017 to Jul 12, 2018 Primary completion date: Jan 15, 2019 to Apr 15, 2019 · Completion date: Jun 15, 2019 to Sep 15, 2019v2 Show 2 more changesShow less
    • Primary completion date: Jan 15, 2019 to Apr 15, 2019
    • Completion date: Jun 15, 2019 to Sep 15, 2019
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects
Trial Details
NCT Number NCT03240809
Lead Sponsor Bausch Health Americas, Inc.
Conditions Psoriasis
Enrollment 2 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov